Current Interventional and Surgical Management of Congenital Heart Disease: Specific Focus on Valvular Disease and Cardiac Arrhythmias

Kimberly A. Holst, Sameh M. Said, Timothy J Nelson, Bryan C. Cannon, Joseph A. Dearani

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Successful outcome in the care of patients with congenital heart disease depends on a comprehensive multidisciplinary team. Surgery is offered for almost every heart defect, despite complexity. Early mortality for cardiac surgery in the neonatal period is ≈10% and beyond infancy is <5%, with 90% to 95% of patients surviving with a good quality of life into the adult years. Advances in imaging have facilitated accurate diagnosis and planning of interventions and surgical procedures. Similarly, advances in the perioperative medical management of patients, particularly with intensive care, has also contributed to improving outcomes. Arrhythmias and heart failure are the most common late complications for the majority of defects, and reoperation for valvar problems is common. Lifelong surveillance for monitoring of recurrent or residual structural heart defects, as well as periodic assessment of cardiac function and arrhythmia monitoring, is essential for all patients. The field of congenital heart surgery is poised to incorporate new innovations such as bioengineered cells and scaffolds that will iteratively move toward bioengineered patches, conduits, valves, and even whole organs.

Original languageEnglish (US)
Pages (from-to)1027-1044
Number of pages18
JournalCirculation Research
Volume120
Issue number6
DOIs
StatePublished - Mar 17 2017

Fingerprint

Cardiac Arrhythmias
Heart Diseases
Thoracic Surgery
Critical Care
Reoperation
Patient Care
Heart Failure
Quality of Life
Mortality

Keywords

  • arrhythmia
  • congenital heart disease
  • heart failure
  • intervention
  • surgery

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Current Interventional and Surgical Management of Congenital Heart Disease : Specific Focus on Valvular Disease and Cardiac Arrhythmias. / Holst, Kimberly A.; Said, Sameh M.; Nelson, Timothy J; Cannon, Bryan C.; Dearani, Joseph A.

In: Circulation Research, Vol. 120, No. 6, 17.03.2017, p. 1027-1044.

Research output: Contribution to journalReview article

Holst, Kimberly A. ; Said, Sameh M. ; Nelson, Timothy J ; Cannon, Bryan C. ; Dearani, Joseph A. / Current Interventional and Surgical Management of Congenital Heart Disease : Specific Focus on Valvular Disease and Cardiac Arrhythmias. In: Circulation Research. 2017 ; Vol. 120, No. 6. pp. 1027-1044.
@article{5ce6e937badd43fbb04905286262a21c,
title = "Current Interventional and Surgical Management of Congenital Heart Disease: Specific Focus on Valvular Disease and Cardiac Arrhythmias",
abstract = "Successful outcome in the care of patients with congenital heart disease depends on a comprehensive multidisciplinary team. Surgery is offered for almost every heart defect, despite complexity. Early mortality for cardiac surgery in the neonatal period is ≈10{\%} and beyond infancy is <5{\%}, with 90{\%} to 95{\%} of patients surviving with a good quality of life into the adult years. Advances in imaging have facilitated accurate diagnosis and planning of interventions and surgical procedures. Similarly, advances in the perioperative medical management of patients, particularly with intensive care, has also contributed to improving outcomes. Arrhythmias and heart failure are the most common late complications for the majority of defects, and reoperation for valvar problems is common. Lifelong surveillance for monitoring of recurrent or residual structural heart defects, as well as periodic assessment of cardiac function and arrhythmia monitoring, is essential for all patients. The field of congenital heart surgery is poised to incorporate new innovations such as bioengineered cells and scaffolds that will iteratively move toward bioengineered patches, conduits, valves, and even whole organs.",
keywords = "arrhythmia, congenital heart disease, heart failure, intervention, surgery",
author = "Holst, {Kimberly A.} and Said, {Sameh M.} and Nelson, {Timothy J} and Cannon, {Bryan C.} and Dearani, {Joseph A.}",
year = "2017",
month = "3",
day = "17",
doi = "10.1161/CIRCRESAHA.117.309186",
language = "English (US)",
volume = "120",
pages = "1027--1044",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Current Interventional and Surgical Management of Congenital Heart Disease

T2 - Specific Focus on Valvular Disease and Cardiac Arrhythmias

AU - Holst, Kimberly A.

AU - Said, Sameh M.

AU - Nelson, Timothy J

AU - Cannon, Bryan C.

AU - Dearani, Joseph A.

PY - 2017/3/17

Y1 - 2017/3/17

N2 - Successful outcome in the care of patients with congenital heart disease depends on a comprehensive multidisciplinary team. Surgery is offered for almost every heart defect, despite complexity. Early mortality for cardiac surgery in the neonatal period is ≈10% and beyond infancy is <5%, with 90% to 95% of patients surviving with a good quality of life into the adult years. Advances in imaging have facilitated accurate diagnosis and planning of interventions and surgical procedures. Similarly, advances in the perioperative medical management of patients, particularly with intensive care, has also contributed to improving outcomes. Arrhythmias and heart failure are the most common late complications for the majority of defects, and reoperation for valvar problems is common. Lifelong surveillance for monitoring of recurrent or residual structural heart defects, as well as periodic assessment of cardiac function and arrhythmia monitoring, is essential for all patients. The field of congenital heart surgery is poised to incorporate new innovations such as bioengineered cells and scaffolds that will iteratively move toward bioengineered patches, conduits, valves, and even whole organs.

AB - Successful outcome in the care of patients with congenital heart disease depends on a comprehensive multidisciplinary team. Surgery is offered for almost every heart defect, despite complexity. Early mortality for cardiac surgery in the neonatal period is ≈10% and beyond infancy is <5%, with 90% to 95% of patients surviving with a good quality of life into the adult years. Advances in imaging have facilitated accurate diagnosis and planning of interventions and surgical procedures. Similarly, advances in the perioperative medical management of patients, particularly with intensive care, has also contributed to improving outcomes. Arrhythmias and heart failure are the most common late complications for the majority of defects, and reoperation for valvar problems is common. Lifelong surveillance for monitoring of recurrent or residual structural heart defects, as well as periodic assessment of cardiac function and arrhythmia monitoring, is essential for all patients. The field of congenital heart surgery is poised to incorporate new innovations such as bioengineered cells and scaffolds that will iteratively move toward bioengineered patches, conduits, valves, and even whole organs.

KW - arrhythmia

KW - congenital heart disease

KW - heart failure

KW - intervention

KW - surgery

UR - http://www.scopus.com/inward/record.url?scp=85015454169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015454169&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.117.309186

DO - 10.1161/CIRCRESAHA.117.309186

M3 - Review article

VL - 120

SP - 1027

EP - 1044

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 6

ER -